Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gliosarcoma × ipatasertib × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 3 Ovarian Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Carcinoma 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1

Interventions

Temozolomide 6 Radiotherapy 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 veliparib 1 sargramostim 1 montanide ISA 51 1 cemiplimab 1 X-Rays 1 Vorinostat 1 Specimen Handling 1 Radiation 1 Photons 1 Perfusion Magnetic Resonance Imaging 1 Contrast Media 1 Colony-Stimulating Factors 1 CTLA-4 Antigen 1 CLR1404 1 Actinium 1 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡